Dr. Nick Neckelmann has a track record of more than 25 years in the Biotech industry covering product development, R&D, marketing, sales, operations management, and investor relations. His recent efforts have focused on molecular clinical diagnostics, genomic analysis, and genetic testing based on Next Generation Sequencing. Previous customer relationships were established with accounts such as Genentech, Quest Diagnostics, Kaiser Permanente, ARUP Laboratories, MD Anderson Cancer Center and multiple academic institutions. Dr. Neckelmann received his PhD from the University of California, Los Angeles, and his BSc from the University of British Columbia.